⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Protalix BioTherapeutics, Inc. Common Stock

$2.48
-0.07 (-2.55%)

Volume:

402.762K ($996.17K)

Market Capitalization:

$199.82M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Protalix BioTherapeutics Market Segments

After Hours

+0.00(+0.00%)
Open$2.48
Close$2.48
Low$2.48
Low Change0.00 (0.00%)
High$2.48
High Change+0.00 (+0.00%)
Range$0.00
Volume39.376K
Dollar Volume$97.65K

Regular Trading Hours

-0.08(-3.04%)
Open$2.55
Close$2.47
Low$2.46
Low Change-0.09 (-3.53%)
High$2.55
High Change+0.00 (+0.00%)
Range$0.09
Volume363.164K
Dollar Volume$897.96K

Premarket

+0.04(+1.56%)
Open$2.49
Close$2.53
Low$2.49
Low Change0.00 (0.00%)
High$2.53
High Change+0.04 (+1.56%)
Range$0.04
Volume222
Dollar Volume$561.66

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$2.55
Close$2.55
Low$2.55
Low Change0.00 (0.00%)
High$2.55
High Change+0.00 (+0.00%)
Range$0.00
Volume30.761K
Dollar Volume$78.44K

Regular Trading Hours Yesterday

+0.01(+0.20%)
Open$2.54
Close$2.55
Low$2.50
Low Change-0.05 (-1.77%)
High$2.56
High Change+0.02 (+0.79%)
Range$0.07
Volume346.858K
Dollar Volume$882.75K

Premarket Yesterday

+0.00(+0.00%)
Open$2.52
Close$2.52
Low$2.52
Low Change0.00 (0.00%)
High$2.52
High Change+0.00 (+0.00%)
Range$0.00
Volume1.27K
Dollar Volume$3.20K

Protalix BioTherapeutics News

There is no current news for this stock at the moment.

Protalix BioTherapeutics Top Trades

Protalix BioTherapeutics's top trade so far today returned +2.36%, while the top short trade returned -3.53%.

Protalix BioTherapeutics Moving Averages

5 Day Moving Average (SMA5)$2.58
10 Day Moving Average (SMA10)$2.64
20 Day Moving Average (SMA20)$2.68
50 Day Moving Average (SMA50)$2.62
100 Day Moving Average (SMA100)$2.45
200 Day Moving Average (SMA200)$2.40

Protalix BioTherapeutics Statistics

Average Volume (30 Days)800.06K
P/E Ratio (Current)11.58
EPS (Current)$0.24
Dividend Yield0.00%
Free Cash Flow$7.67M
Cash Ratio0.87
Current Ratio2.94
Quick Ratio1.91
Debt to Equity0.00
Enterprise Value$196.57M
EV to EBITDA7.91
EV to Sales2.44
Price to Book3.14
Price to Cash Flow22.57
Price to Free Cash Flow29.21
Price to Sales2.78
Return on Assets0.17%
Return on Equity0.27%

Protalix BioTherapeutics Stock Splits

There has been 1 stock split for Protalix BioTherapeutics (PLX). The reverse stock split occured on December 20, 2019 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Dec 20, 2019Reverse10:1

Protalix BioTherapeutics Dividends

There have been no dividends for Protalix BioTherapeutics (PLX).